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Two novel a-linked sialyltrisaccharide imidazolium-type probes (ITags) based on the structures of
biologically relevant 60-sialyllactosamine and 30-sialyllactosamine were efﬁciently and stereoselectively
prepared using a chemo-enzymatic approach. The apparent kinetic parameters for the enzyme catalyzed
transformations with a-2,3-sialyltransferase (a-2,3-ST) and a-2,6-sialyltransferase (a-2,6-ST) were mea-
sured by LC–MS using the ionic probes. This strategy demonstrates the suitability of the ITags to probe
glycosyltransferase activity and their versatility in the preparation of sialylated epitopes for glycobiology
research.
 2015 The Authors. Published by Elsevier Ltd. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).Sialic acids are a diverse family of sugar units with a
nine-carbon backbone that are typically found as terminal residues
on oligosaccharide chains of various cell-surface glycoproteins and
glycolipids and on secreted proteins in vertebrates.1,2 These unique
molecules mediate a wide range of biological processes, including
intercellular adhesion, signaling and microbial attachment.3 For
instance, the a-linked sialyltrisaccharides 30-sialyllactosamine
(Neu5Ac-a2,3-Gal-b1,4-GlcNAc-b-OR, 1) and 60-sialyllactosamine
(Neu5Ac-a2,6-Galb1,4-GlcNAc-b-OR, 2) are ligands for inﬂuenza
viruses.3–5
In order to gain a better understanding of the role and function
of these important glycan structures in normal physiology and dis-
ease and to evaluate their therapeutic potential, efﬁcient and prac-
tical synthetic methods to access structurally deﬁned sialylated
glycan probes are needed.6 However, despite the many advances
in the area, the chemical synthesis of sialic acid containing
oligosaccharides still represents a signiﬁcant challenge. Most
approaches rely on lengthy and time consuming chemical steps
to achieve good yields and stereocontrol, mostly due to the hin-
dered and charged tertiary anomeric center and the lack of a par-
ticipating group to aid in stereochemical control.7–11 As an
alternative, the use of glycosyltransferases to construct oligosac-
charides offers several advantages over chemical approaches,
when the corresponding enzymes and required sugar nucleotidesare available, since these enzymes are able to form glycosidic
bonds with exquisite regio- and stereocontrol by catalyzing the
transfer of an activated sugar donor to growing oligosaccharide
chains without the need for protecting groups.12
Imidazolium based ionic liquids (ILs) have emerged as a popular
class of reagents in organic chemistry as new vehicles for the immo-
bilization of reagents due to their unique physical and chemical
properties.13,14 In addition, ILs are also ideal as mass spectrometry
(MS) probes for fast reaction analysis because of their greater spec-
tral peak intensities and lower limits of detection.15 Our group
recently reported the synthesis of inexpensive and versatile imida-
zolium-based probes for fast and sensitive reaction monitoring by
MS as an alternative to expensive radioactive or ﬂuorescent
labels.14,16–18 In our work, we demonstrated that the ionic tags
(ITags) are compatible with several glycosyltransferases and the
ionic probes were employed in the qualitative and quantitative bio-
logical characterization of bovine milk b-1,4-galactosyltransferase
(b-1,4-GalT)16 and b-1,3-fucosyltransferase (a-1,3-FucT VI).18
Encouraged by the simplicity and practicality of our approach,
we decided to expand the use of the new probes to another
important class of targets. Herein we report the efﬁcient chemo-
enzymatic synthesis of a-2,3 and a-2,6-sialyllactosamine
ionic-probes. Both trisaccharides were prepared in mg scale from
a common intermediate, ITag-LacNAc (Gal-b1,4-GlcNAc-ITag, 4).
Furthermore, the apparent kinetic parameters for the enzymatic
sialylations were measured using the ionic probes and are also
reported.
Scheme 2. Enzymatic synthesis of ITagged a-2,3/6 sialylated LacNAc 5 and 6,
respectively.
Figure 2. LC–MS traces of ITag-probes. (A) TIC trace for 6 [M+] 966; (B) TIC trace for
5 [M+] 966; (C) TIC trace for 4 [M+] 675.
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sialyltransferases, which are a group of glycosyltransferases that,
independent of their source and acceptor speciﬁcity, transfer sialic
acid from cytidine monophosphate N-acetylneuraminic acid
(CMP-Neu5Ac) to acceptor oligosaccharides found in glycopro-
teins, glycolipids or polysaccharides.19 It has been estimated that
there are more than 20 different mammalian sialyltransferases.20
Each of these enzymes is classiﬁed on the basis of the position of
attachment to the acceptor being either a-2,3-, a-2,6- or a-2,8-
linked and their speciﬁcity for its acceptor substrate.21,22 For
instance, two different sialyltransferases, a-2,3-sialyltransferase
(a-2,3-ST) and a-2,6-sialyltransferase (a-2,6-ST) are required to
introduce the N-acetylneuraminic acid (Neu5Ac) groups at C60
and C30 of the LacNAc disaccharide core, respectively (Fig. 1).
In our previous work, we developed a N-benzenesulfonyl-type
ITag for covalent attachment to glycan substrates.18 The labels
are stable to chemical and enzymatic media, readily accessed from
commercial materials and contain both a MS probe and a UV moi-
ety for reaction monitoring. Thus, we envisaged that these types of
ionic probes would be suitable for the preparation of the sialylated
compounds. To that end, core disaccharide ITag-LacNAc 4 was
enzymatically prepared in a 95% yield from the reaction of ITag-
GlcNAc 318 with an excess of uridine 50-diphosphogalactose
(UDP-Gal) in the presence of bovine milk b-1,4-GalT as the catalyst
(see Scheme 1).
With ITag-LacNAc 4 in hand, we ﬁrst had to ensure that both
sialyltransferases were able to tolerate the presence of the
sulfonamide-containing ITag. To our delight, incubation of 4 with
a-2,3-ST (50 mU) and CMP-Neu5Ac in 3-morpholinopropane-1-
sulfonic acid (MOPS) buffer (50 mM, pH 7.9) at 37 C afforded the
desired trisaccharide product 5 in 96% yield after 7 h
(Scheme 2).23 The structure of 5 was conﬁrmed by LC–MS
(M+ = 966) and the characteristic signals in the 1H-NMR spectrum
(dH3a00 = 2.78 ppm, J3a00 ,3b00 = 12.5, J3a00 ,400 = 4.7 Hz, dH3b00 = 1.82 ppm,
J3b00 ,3a00 = J3b00 ,400 = 12.1 Hz) (Fig. 2B). Similarly, a-2,6-ST was also able
to catalyze the conversion of 4 into 60-sialyllactosamine analogue 6
under the same reaction conditions, although the reaction
appeared to be slower, and after 14 h, 6was produced in 65% yield.
LC–MS (M+ = 966) and NMR were used to conﬁrm the structure ofFigure 1. Naturally occurring sialylLacNAc derivatives 1 and 2.
Scheme 1. Chemo-enzymatic synthesis of core ITag-LacNAc 4.the trisaccharide (dH3a00 = 2.69 ppm, J3a00 ,3b00 = 12.4, J3a00 ,400 = 4.6 Hz,
dH3b00 = 1.72 ppm, J3b00 ,3a00 = J3b00 ,400 = 12.4 Hz) (Fig. 2A).24
Encouraged by our results, we then decided to obtain the appar-
ent kinetic parameters for ITag probe 4 with the two different sia-
lyltransferases using previously reported assays18,19 and the ITag
as the reporting handle. Thus, LC–MS was used to monitor and
quantify reaction progress. Assays were performed in duplicate
using the appropriate amount of each enzyme. The concentration
of the oligosaccharide acceptor was varied around the KM value,
whereas the concentration of CMP-Neu5Ac was kept constant at
0.5 mM and CMP-Neu5Ac consumption was limited to 10–15% to
ensure initial rate conditions.25
The apparent KM value for ITag-derivative 4 with a-2,3-ST was
determined to be 0.5 ± 0.1 mM with a catalytic efﬁciency
(kcat/KM) of 21.8 min1 mM1 (Table 1 and Fig. 3A). On the other
hand, the apparent KM value for 4 with a-2,6-ST was measured
to be 2.6 ± 0.1 mM with a catalytic efﬁciency (kcat/KM) of
2.8 min1 mM1 (Table 1 and Fig. 3B). Although both enzymes
are able to turnover ITag-LacNAc 4 efﬁciently, the catalytic efﬁ-
ciency for the a-2,6-ST was around 8 times lower than that
observed for the same substrate with the a-2,3-ST. This is not com-
pletely unexpected as different enzymes can react differently to
the same chemical modiﬁcation29 and perhaps the presence of an
imidazolium moiety in close proximity to the anomeric position
of the substrate is detrimental for catalytic activity. Indeed, relative
rates of transfer for both enzymes with ITag-LacNAc 4 and naturalTable 1
Apparent kinetic parameters for a-2,3- and a-2,6-ST with ITag-LacNAc 4 as substrate
Enzyme KM [mM] Vmax
[lMmin1]
kcat [min1] kcat/KM
[min1 mM1]
a-2,3-ST 0.5 ± 0.1 11.8 ± 0.9 10.9 21.8
a-2,6-ST 2.6 ± 0.1 2.0 ± 0.1 7.2 2.8
Table 2
Relative rates of transfer measured at 1.0 mM of 4 and 7, respectively and 0.5 mM of
CMP-Neu5Aca
Enzyme ITag-LacNAc 4 LacNAc 7
a-2,3-ST 10.6 100
a-2,6-ST 1.4 69
a-2,3-ST (0.5 lg of protein) and a-2,6-ST (0.8 lg of protein).
a Values normalized to enzyme concentration.
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Figure 3. Michaelis–Menten curves for the reaction of ITag-LacNac 4 with
(A) a-2,3-ST and (B) a-2,6-ST.
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ITag-group are signiﬁcantly less efﬁcient than those carried out
with a substrate without the ionic modiﬁcation. Moreover, the
a-2,3-ST enzyme is able to turn over LacNAc 7 at a slightly higher
rate than the a-2,6-ST (see Table 2).
It is important to note that KM values for both enzymes are sim-
ilar to those reported for other LacNAc analogues with modiﬁca-
tions at the anomeric position.26–28
In Summary, we have developed a practical and stereoselec-
tive chemo-enzymatic approach for the efﬁcient synthesis of
two novel a-linked sialyltrisaccharide imidazolium-containing
probes (ITags) based on the structures of 30-sialyllactosamine
and 60-sialyllactosamine. We also obtained the apparent kinetic
data for ITag-substrate 4 with the two sialyltransferases a-2,3-
ST and a-2,6-ST. We were able to employ the ITag probes as
MS reporters, without the need for expensive radiolabels or ﬂu-
orophores, demonstrating the practicality and versatility of
these types of ionic labels. The novel ITag-analogues will be
employed for selective metabolic inhibition of oligosaccharide
biosynthesis and the results of these studies will be reported
in due course.
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